Correlation Between Nkarta and Bright Minds
Can any of the company-specific risk be diversified away by investing in both Nkarta and Bright Minds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nkarta and Bright Minds into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nkarta Inc and Bright Minds Biosciences, you can compare the effects of market volatilities on Nkarta and Bright Minds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nkarta with a short position of Bright Minds. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nkarta and Bright Minds.
Diversification Opportunities for Nkarta and Bright Minds
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Nkarta and Bright is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and Bright Minds Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bright Minds Biosciences and Nkarta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nkarta Inc are associated (or correlated) with Bright Minds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bright Minds Biosciences has no effect on the direction of Nkarta i.e., Nkarta and Bright Minds go up and down completely randomly.
Pair Corralation between Nkarta and Bright Minds
Given the investment horizon of 90 days Nkarta Inc is expected to under-perform the Bright Minds. But the stock apears to be less risky and, when comparing its historical volatility, Nkarta Inc is 17.95 times less risky than Bright Minds. The stock trades about -0.13 of its potential returns per unit of risk. The Bright Minds Biosciences is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 126.00 in Bright Minds Biosciences on August 26, 2024 and sell it today you would earn a total of 3,407 from holding Bright Minds Biosciences or generate 2703.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nkarta Inc vs. Bright Minds Biosciences
Performance |
| Timeline |
| Nkarta Inc |
| Bright Minds Biosciences |
Nkarta and Bright Minds Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nkarta and Bright Minds
The main advantage of trading using opposite Nkarta and Bright Minds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nkarta position performs unexpectedly, Bright Minds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will offset losses from the drop in Bright Minds' long position.| Nkarta vs. Eliem Therapeutics | Nkarta vs. HCW Biologics | Nkarta vs. Scpharmaceuticals | Nkarta vs. Milestone Pharmaceuticals |
| Bright Minds vs. Revelation Biosciences | Bright Minds vs. Zura Bio Limited | Bright Minds vs. Phio Pharmaceuticals Corp | Bright Minds vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |